2-(2-Methoxy-5-methylphenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane, 98%, 25g

4-Phenyl-2-pyrrolidone>98.0%(GC)1g

1-BOC-3-BROMO-1H-PYRROLO[3,2-B]PYRIDINE, 95.0%, 1g

Tiapride Hydrochloride, >99.0%(HPLC)(T), 250mg

Pyridine, ROTICHROM® GC , 5 ml, glass packaging

7-Bromo-2-naphthoic acid, 95%, 250mg

4,4',4''-((1,3,5-Triazine-2,4,6-triyl)tris(oxy))trianiline, 97%, 5g

2-Methoxyquinoline, 95.0%, 5g

3'-(Methylthio)acetophenone, 97.0%, 1g

2-Hydroxy-4-isopropylbenzaldehyde, 97%, 1g

Plan Fluarex PLFi 4x/0.13 IOS infinity corrected objective. Working distance 16.3 mm

9-(2-Hydroxyethyl)adenine>98.0%(HPLC)(T)25g

(R)-6-(propylamino)-5,6,7,8-tetrahydronaphthalen-1-ol hydrobromide, 98%, 25mg